A1405112
Iniparib (BSI-201) , ≥98% , 160003-66-7
Synonym(s):
4-Iodo-3-nitrobenzamide;BSI-201
CAS NO.：160003-66-7
Empirical Formula: C7H5IN2O3
Molecular Weight: 292.03
MDL number: MFCD11110639
EINECS: 685-396-9
| Pack Size | Price | Stock | Quantity |
| 10MG | RMB23.20 | In Stock |
|
| 50MG | RMB39.20 | In Stock |
|
| 250MG | RMB69.60 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 150-153° |
| Boiling point: | 344.8±32.0 °C(Predicted) |
| Density | 2.055±0.06 g/cm3(Predicted) |
| storage temp. | Sealed in dry,Store in freezer, under -20°C |
| solubility | DMSO: soluble5mg/mL, clear |
| pka | 14?+-.0.50(Predicted) |
| form | powder |
| color | white to beige |
| Stability: | Stable for 1 year from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 3 months. |
Description and Uses
Iniparib (160003-66-7) was originally thought to be a PARP1 inhibitor but this is controversial.1,2?Inhibits ionizing radiation-induced single-stranded DNA break repair in lymphoid cell lines?in vivo.3?Inhibits growth of certain breast cancer cell lines?in vitro. Iniparib non-selectively modifies cysteine-containing proteins in tumor cells.4
Iniparib is an irreversible PARP1 inhibitor. Studies show that potential therapeutic agent for the treatment of cancer, including triple-negative breast cancer.
